You are here

  • Home
  • Online First
  • Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

Article Text

Article menu

other Versions

Download PDFPDF
Review
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)
  1. Gemma Mancebo1,
  2. Josep-Maria Solé-Sedeño1,
  3. Ismael Membrive2,
  4. Alvaro Taus3,
  5. Marta Castells1,
  6. Laia Serrano4,
  7. Ramon Carreras1 and
  8. Ester Miralpeix1
  1. 1Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain
  2. 2Department of Radiation Oncology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain
  3. 3Department of Medical Oncology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain
  4. 4Department of Pathology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain
  1. Correspondence to Dr Gemma Mancebo, Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Passeig Marítim 25-29, E-08003 Barcelona, Spain; GMancebo{at}parcdesalutmar.cat

Abstract

The SARS-CoV-2 (COVID-19) pandemic has significantly impacted the management of patients with gynecologic cancers. Many centers have reduced access to routine visits to avoid crowded waiting areas and specially to reduce the infection risk for oncologic patients. The goal of this review is to propose a surveillance algorithm for patients with gynecologic cancers during the COVID-19 pandemic based on existing evidence and established guidelines. It is time to consider strategies based on telemedicine and to adapt protocols in this new era. We hereby propose a strategy for routine surveillance both during and beyond the pandemic.

  • gynecology
  • ovarian cancer
  • endometrial neoplasms
  • cervical cancer

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

https://doi.org/10.1136/ijgc-2020-001942

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @twigem2a, @solesedeno, @ester_miralpeix

    • Contributors AT, IM, GM, EM, and JMSS reviewed guidelines. AT, IM, and GM discussed and proposed a follow-up guide. JMSS designed figures. RC, LS, EM, and MC reviewed the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.